rs371172166
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000092.5(COL4A4):c.3022G>A(p.Gly1008Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000192 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000092.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152112Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 249560Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135400
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461862Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 727238
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74426
ClinVar
Submissions by phenotype
not provided Pathogenic:3
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1008 of the COL4A4 protein (p.Gly1008Arg). This variant is present in population databases (rs371172166, gnomAD 0.02%). This missense change has been observed in individuals with clinical features of autosomal dominant Alport syndrome (PMID: 26809805, 37895203; internal data). ClinVar contains an entry for this variant (Variation ID: 552195). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt COL4A4 protein function with a positive predictive value of 95%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Affects a glycine residue in a Gly-X-Y motif in the triple helical region of the COL4A4 gene, where the majority of pathogenic missense variants occur, and is predicted to disrupt normal protein folding and function (HGMD; PMID: 10752524); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 37895203, 26809805, 10752524) -
COL4A4: PM2, PP4:Moderate, PS4:Moderate -
Autosomal recessive Alport syndrome;CN376803:Hematuria, benign familial, 1 Pathogenic:1
- -
COL4A4-related disorder Pathogenic:1
The COL4A4 c.3022G>A variant is predicted to result in the amino acid substitution p.Gly1008Arg. This variant affects a glycine (Gly) residue of the conserved triple helical domain (residues 65 – 1459) of the COL4A4 protein (uniprot.org), where substitutions of the glycine (Gly) residue are usually pathogenic (Hudson et al. 1993. PubMed ID: 8253711; https://www.ncbi.nlm.nih.gov/books/NBK1207/). This variant has been reported in a male child (8 years old at examination) with thin basement membrane nephropathy (TBMN) and it was inherited from his father with Alport syndrome (see family #12290513 in Weber et al. 2016. PubMed ID: 26809805). This variant is reported in 0.025% of alleles in individuals of African descent in gnomAD. This variant is interpreted as pathogenic. -
Autosomal recessive Alport syndrome Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at